Literature DB >> 16760788

Resorptive response of rhBMP2 simulating infection in an anterior lumbar interbody fusion with a femoral ring.

Stephen M Hansen1, Rick C Sasso.   

Abstract

RhBMP-2 has been available for general use since July of 2002. No literature regarding its use with femoral ring allografts exists. This case demonstrates how a resorptive effect of rhBMP-2 with a femoral ring allograft on host bone at the interbody fusion site can easily be confused with infection. Spine surgeons should be aware of this effect to avoid unnecessary antibiotic use or additional surgery.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16760788     DOI: 10.1097/01.bsd.0000168512.61351.3a

Source DB:  PubMed          Journal:  J Spinal Disord Tech        ISSN: 1536-0652


  11 in total

Review 1.  Interaction of bone morphogenetic proteins with cells of the osteoclast lineage: review of the existing evidence.

Authors:  P V Giannoudis; N K Kanakaris; T A Einhorn
Journal:  Osteoporos Int       Date:  2007-08-12       Impact factor: 4.507

2.  Adverse effects of posterior lumbar interbody fusion using rhBMP-2.

Authors:  Tomislav Smoljanovic; Ivan Bojanic; Domagoj Delimar
Journal:  Eur Spine J       Date:  2009-04-08       Impact factor: 3.134

Review 3.  The clinical use of bone morphogenetic proteins revisited: a novel biocompatible carrier device OSTEOGROW for bone healing.

Authors:  Slobodan Vukicevic; Hermann Oppermann; Donatella Verbanac; Morana Jankolija; Irena Popek; Jasna Curak; Jelena Brkljacic; Martina Pauk; Igor Erjavec; Igor Francetic; Ivo Dumic-Cule; Mislav Jelic; Dragan Durdevic; Tomislav Vlahovic; Ruder Novak; Vera Kufner; Tatjana Bordukalo Niksic; Marija Kozlovic; Zrinka Banic Tomisic; Jadranka Bubic-Spoljar; Ivancica Bastalic; Smiljka Vikic-Topic; Mihaela Peric; Marko Pecina; Lovorka Grgurevic
Journal:  Int Orthop       Date:  2013-12-19       Impact factor: 3.075

Review 4.  A Review of the Clinical Side Effects of Bone Morphogenetic Protein-2.

Authors:  Aaron W James; Gregory LaChaud; Jia Shen; Greg Asatrian; Vi Nguyen; Xinli Zhang; Kang Ting; Chia Soo
Journal:  Tissue Eng Part B Rev       Date:  2016-04-19       Impact factor: 6.389

Review 5.  Bone morphogenetic protein use in spine surgery-complications and outcomes: a systematic review.

Authors:  Antonio Faundez; Clément Tournier; Matthieu Garcia; Stéphane Aunoble; Jean-Charles Le Huec
Journal:  Int Orthop       Date:  2016-03-10       Impact factor: 3.075

6.  Evaluation of complications associated with off-label use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in pediatric orthopaedics.

Authors:  Norbert Stiel; Tim N Hissnauer; Martin Rupprecht; Kornelia Babin; Carsten W Schlickewei; Johannes M Rueger; Ralf Stuecker; Alexander S Spiro
Journal:  J Mater Sci Mater Med       Date:  2016-10-27       Impact factor: 3.896

7.  A Pre-clinical Standard Operating Procedure for Evaluating Orthobiologics in an In Vivo Rat Spinal Fusion Model.

Authors:  Andrew L Alejo; Scott McDermott; Yusuf Khalil; Hope C Ball; Gabrielle T Robinson; Ernesto Solorzano; Amanda M Alejo; Jacob Douglas; Trinity K Samson; Jesse W Young; Fayez F Safadi
Journal:  J Orthop Sports Med       Date:  2022-09-05

8.  Bone morphogenetic protein 2 enhances PGE(2)-stimulated osteoclast formation in murine bone marrow cultures.

Authors:  Katherine A Blackwell; Peter Hortschansky; Srdan Sanovic; Shilpa Choudhary; Lawrence G Raisz; Carol C Pilbeam
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-09-08       Impact factor: 3.072

9.  Treatment of pediatric spinal deformity with use of recombinant human bone morphogenetic protein-2.

Authors:  Norbert Stiel; Ralf Stuecker; Philip Kunkel; Karsten Ridderbusch; Christian Hagemann; Sandra Breyer; Nicola Ebert; Alexander S Spiro
Journal:  J Mater Sci Mater Med       Date:  2018-06-25       Impact factor: 3.896

Review 10.  The controversy surrounding bone morphogenetic proteins in the spine: a review of current research.

Authors:  Joshua W Hustedt; Daniel J Blizzard
Journal:  Yale J Biol Med       Date:  2014-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.